We are into six months of the two year plan, on schedule, entered the deal window for all three indications with transactions happening moreso earlier in the clinic phases.
Plenty of data flow ahead.
Rerate potential seemingly anytime... But I'd say that longer time for more data and clinic progress the better the $ outcome.
18 months deal countdown now on for all three indications with finance optionality (from a deal on one of three) to go alone, plenty of cash from recent raise.
Ann: Q2 2024 Investor Webinar Presentation, page-15
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.005(4.00%) |
Mkt cap ! $606.5M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 13.0¢ | 12.0¢ | $415.6K | 3.255M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 112056 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 127118 | 2 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |